当前位置:首页 - 行情中心 - 南京医药(600713) - 财务分析 - 现金流量表

南京医药

(600713)

  

流通市值:67.72亿  总市值:68.68亿
流通股本:12.90亿   总股本:13.08亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金35,146,280,790.723,414,143,871.949,922,819,614.2855,386,611,479.09
  收到其他与经营活动有关的现金937,730,344.63234,459,165.04580,491,334.35273,819,883.97
  经营活动现金流入小计36,084,011,135.3323,648,603,036.9810,503,310,948.6355,660,431,363.06
  购买商品、接受劳务支付的现金40,498,491,939.5427,143,786,798.3814,548,411,289.4652,758,765,664.94
  支付给职工以及为职工支付的现金784,875,134.47541,205,675.89310,417,803.151,008,889,614.83
  支付的各项税费783,576,119.72577,927,562.29279,076,591.64905,693,399
  支付其他与经营活动有关的现金579,499,581.19545,461,922.81559,906,339.75895,273,755.34
  经营活动现金流出小计42,646,442,774.9228,808,381,959.3715,697,812,02455,568,622,434.11
  经营活动产生的现金流量净额-6,562,431,639.59-5,159,778,922.39-5,194,501,075.3791,808,928.95
二、投资活动产生的现金流量:
  收回投资收到的现金527,000,000385,000,000215,000,0001,249,000,000
  取得投资收益收到的现金1,889,795.21,114,544.52674,808.226,464,475.71
  处置固定资产、无形资产和其他长期资产收回的现金净额38,969,170.0533,610,081.534,102,435.64269,104,946.56
  投资活动现金流入小计567,858,965.25419,724,626.05219,777,243.861,524,569,422.27
  购建固定资产、无形资产和其他长期资产支付的现金140,899,513.02108,470,362.2369,156,484.45251,374,104.16
  投资支付的现金462,800,000328,000,000188,000,0001,468,900,000
  取得子公司及其他营业单位支付的现金201,969,841.351,917.2251,917.22-
  支付其他与投资活动有关的现金244,691,966---
  投资活动现金流出小计1,050,361,320.32436,522,279.45257,208,401.671,720,274,104.16
  投资活动产生的现金流量净额-482,502,355.07-16,797,653.4-37,431,157.81-195,704,681.89
三、筹资活动产生的现金流量:
  吸收投资收到的现金287,199,00022,940,000-71,595,180
  其中:子公司吸收少数股东投资收到的现金287,199,00022,940,000-71,595,180
  取得借款收到的现金15,626,961,450.3513,543,306,206.27,123,845,116.0316,463,072,465.81
  发行债券收到的现金7,000,000,0005,000,000,0002,000,000,0005,572,528,735.85
  收到其他与筹资活动有关的现金---44,336,880
  筹资活动现金流入小计22,914,160,450.3518,566,246,206.29,123,845,116.0322,151,533,261.66
  偿还债务支付的现金16,251,329,905.5713,148,139,985.794,900,063,881.9721,779,415,024.51
  分配股利、利润或偿付利息支付的现金639,735,790.67460,003,894.71103,496,069.24617,612,347.6
  其中:子公司支付给少数股东的股利、利润106,596,027.2691,531,143.62-124,982,809.89
  支付其他与筹资活动有关的现金108,662,207.4546,977,852.7822,112,767.93185,436,435.51
  筹资活动现金流出小计16,999,727,903.6913,655,121,733.285,025,672,719.1422,582,463,807.62
  筹资活动产生的现金流量净额5,914,432,546.664,911,124,472.924,098,172,396.89-430,930,545.96
五、现金及现金等价物净增加额-1,130,501,448-265,452,102.87-1,133,759,836.29-534,826,298.9
  加:期初现金及现金等价物余额2,393,310,157.652,393,310,157.652,393,310,157.652,928,136,456.55
  期末现金及现金等价物余额1,262,808,709.652,127,858,054.781,259,550,321.362,393,310,157.65
补充资料:
  净利润-378,501,024.19-832,668,876.52
  资产减值准备-4,212,882.79-25,113,091.63
  固定资产和投资性房地产折旧-66,068,267.74-132,876,091.13
  无形资产摊销-14,401,471.88-32,063,214.79
  长期待摊费用摊销-5,636,207.55-28,624,025.16
  处置固定资产、无形资产和其他长期资产的损失--2,970,207.79--293,312,740.32
  固定资产报废损失-136,599.89--
  公允价值变动损失--410,597.27--282,526.03
  财务费用-139,864,841.66-309,014,785.81
  投资损失--3,530,736.72--4,793,861.74
  递延所得税--25,790,447.46--25,233,071.69
  其中:递延所得税资产减少--16,542,056.63--30,054,456.86
    递延所得税负债增加--9,248,390.83-4,821,385.17
  存货的减少-69,482,728.16--617,697,096.08
  经营性应收项目的减少--5,234,532,103.42--1,584,295,480.33
  经营性应付项目的增加--711,235,204.89-947,267,571.58
  现金的期末余额-2,127,858,054.78-2,393,310,157.65
  减:现金的期初余额-2,393,310,157.65-2,928,136,456.55
  现金及现金等价物的净增加额--265,452,102.87--534,826,298.9
公告日期2026-10-312026-08-292026-04-302026-04-11
审计意见(境内)标准无保留意见
TOP↑